High level panel to recommend reforms in India’s drug regulatory system

Government of India has formed a high-level committee of experts to recommend reforms in India’s drug regulatory system so that approval processes can be fast-tracked.

The committee chaired by Rajesh Bhushan, the OSD to the Union health minister, comprises top drug and vaccine entrepreneurs of India along with officers nominated from the Department of Pharmaceuticals, Department of Biotechnology, Indian Pharmacopoeia Commission, Indian Pharmaceutical Alliance, ICMR along with public health expert from AIIMS.

The committee will study the current drug regulatory system and submit recommendations for reforms, so as to bring the system in line with global standards and make it more efficient.